657—23.14(124,155A) Provision of drugs to a facility for immunization or screening programs. A pharmacy may provide drugs to be used in the care facility for a health immunization or ongoing screening program, such as influenza vaccine, tuberculin skin test, or hepatitis-B.
	23.14(1) Labeling. The pharmacy label shall be affixed so as not to obscure the manufacturer’s label and shall include the following information.
	a. 	Identification of pharmacy;
	b. 	Name of facility;
	c. 	Name of biological or drug;
	d. 	Route of administration when necessary for clarification;
	e. 	Strength of biological or drug;
	f. 	Auxiliary labels as needed;
	g. 	Date dispensed.
	23.14(2) Influenza and pneumococcal vaccines. A patient-specific medication order shall not be required prior to administration to an adult patient of influenza or pneumococcal vaccines pursuant to physician-approved facility policy and after the patient has been assessed for contraindications.
	23.14(3) Notification. The facility shall submit to the provider pharmacy a listing of those residents or staff members who have been immunized utilizing vaccine from each vial supplied by the provider pharmacy no later than seven days following administration of the vaccine.
[ARC 3859C, IAB 6/20/18, effective 7/25/18; ARC 6685C, IAB 11/30/22, effective 1/4/23]